Eli Lilly CR, S.R.O. is the Czech subsidiary of Eli Lilly and Company, responsible for the marketing, distribution and regulatory support of the company's pharmaceuticals in the Czech Republic. Its portfolio includes medicines in diabetes, oncology, immunology, neuroscience and other therapeutic areas. The company supports medical education, clinical research, pharmacovigilance and collaboration with healthcare professionals and institutions. Customers include hospitals, specialised centres, pharmacies and wholesalers. Key assets consist of Lilly's global research based product portfolio, local commercial and medical teams and integration into the global Lilly supply and research network. Strategically, Eli Lilly CR functions as an innovative pharmaceutical affiliate focused on bringing modern therapies to Czech patients and supporting evidence based treatment.
Headquarters
Pobrezni 394/12
Prague; The City of Prague;
Postal Code: 18600
Contact Details: Purchase the Eli Lilly Cr, S.R.O. report to view the information.
Website: https://www.lilly.cz
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service